Is Hemoglobin Level in Patients with Nasopharyngeal Carcinoma Still a Significant Prognostic Factor in the Era of Intensity-Modulated Radiotherapy Technology?

Is Hemoglobin Level in Patients with Nasopharyngeal Carcinoma Still a Significant Prognostic Factor in the Era of Intensity-Modulated Radiotherapy Technology?

BACKGROUND:Hemoglobin (Hb) levels are regarded as an important determinant of outcome in a number of cancers treated with radiotherapy. However, for patients treated with intensity modulated radiotherapy (IMRT), information regarding the prognostic value of hemoglobin level is scarce. PATIENTS AND M...

Full description

Bibliographic Details
Main Authors:	Shan-Shan Guo, Lin-Quan Tang, Qiu-Yan Chen, Lu Zhang, Li-Ting Liu, Pei-Yu Huang, Ka-Jia Cao, Ling Guo, Hao-Yuan Mo, Xiang Guo, Ming-Huang Hong, Mu-Sheng Zeng, Chao-Nan Qian, Hai-Qiang Mai
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4552389?pdf=render

Similar Items

Elevated high-sensitivity C-reactive protein levels predict decreased survival for nasopharyngeal carcinoma patients in the intensity-modulated radiotherapy era.
by: Lin Quan Tang, et al.
Published: (2015-01-01)

Prognostic Value of Inflammatory Markers in Nasopharyngeal Carcinoma Patients in the Intensity-Modulated Radiotherapy Era
by: Li Q, et al.
Published: (2021-08-01)

Intensive Local Radiotherapy Is Associated With Better Local Control and Prolonged Survival in Bone-Metastatic Nasopharyngeal Carcinoma Patients
by: Xiao-Yun Li, et al.
Published: (2020-03-01)

Prognostic significance of tumor volume in locally recurrent nasopharyngeal carcinoma treated with salvage intensity-modulated radiotherapy.
by: WeiWei Xiao, et al.
Published: (2015-01-01)

Prognostic Value of Pretreatment Serum Cystatin C Level in Nasopharyngeal Carcinoma Patients in the Intensity-modulated Radiotherapy Era
by: Tan XR, et al.
Published: (2021-01-01)

Induction chemotherapy followed by radiotherapy concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma
by: Li-Ting Liu, et al.
Published: (2020-06-01)

Prognostic significance of the long noncoding RNAs in nasopharyngeal carcinoma: a systematic review and meta-analysis
by: Guo H, et al.
Published: (2018-06-01)

Concurrent chemotherapy for T4 classification nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.
by: Cai-neng Cao, et al.
Published: (2015-01-01)

Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy
by: Jin-Hao Yang, et al.
Published: (2021-05-01)

The prognostic significance of carcinoma-associated fibroblasts and tumor-associated macrophages in nasopharyngeal carcinoma
by: Yu Y, et al.
Published: (2018-07-01)

Different prognostic values of plasma Epstein-Barr virus DNA and maximal standardized uptake value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients with recurrence.
by: Ting Shen, et al.
Published: (2015-01-01)

Longitudinal Trend of Health-Related Quality of Life During Concurrent Chemoradiotherapy and Survival in Patients With Stage II–IVb Nasopharyngeal Carcinoma
by: Ji-Bin Li, et al.
Published: (2020-10-01)

The development and external validation of simplified T category classification for nasopharyngeal carcinoma to improve the prognostic value in the intensity‐modulated radiotherapy era
by: Ling‐Long Tang, et al.
Published: (2019-05-01)

Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: a meta-analysis
by: He Y, et al.
Published: (2018-06-01)

Recommendations for Updating T and N Staging Systems for Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy.
by: Zhong-Guo Liang, et al.
Published: (2016-01-01)

Prognostic Value of Cavernous Sinus Invasion in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
by: Jun-Fang Liao, et al.
Published: (2016-01-01)

Prognostic value and staging classification of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
by: Ling-Long Tang, et al.
Published: (2014-01-01)

Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.
by: Shixiu Wu, et al.
Published: (2015-01-01)

Secondary Nasopharyngeal Mixed Adenoneuroendocrine Carcinoma After Radical Radiotherapy for Nasopharyngeal Carcinoma: A Rare Case and Literature Review
by: Huang D, et al.
Published: (2021-02-01)

The Efficacy of Radiotherapy for Nasopharyngeal Carcinoma under Magnetic Resonance Imaging
by: Hao Zhang, et al.
Published: (2021-01-01)

A matched cohort study of standard chemo-radiotherapy versus radiotherapy alone in elderly nasopharyngeal carcinoma patients.
by: Qi Zeng, et al.
Published: (2015-01-01)

Prognostic significance and therapeutic implications of centromere protein F expression in human nasopharyngeal carcinoma
by: Cao Jing-Yan, et al.
Published: (2010-09-01)

Which nasopharyngeal cancer patients need adaptive radiotherapy?
by: Yu-Chang Hu, et al.
Published: (2018-12-01)

Clinical Characteristics and Prognostic Factors of Early and Late Recurrence After Definitive Radiotherapy for Nasopharyngeal Carcinoma
by: Feng Li, et al.
Published: (2020-08-01)

Nomogram Predicting the Benefits of Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy After Induction Chemotherapy in Stages II–IVb Nasopharyngeal Carcinoma
by: Sai-Lan Liu, et al.
Published: (2020-11-01)

T4-Locally Advanced Nasopharyngeal Carcinoma: Prognostic Influence of Cranial Nerve Involvement in Different Radiotherapy Techniques
by: Hsin-I Huang, et al.
Published: (2013-01-01)

Assessment of Salivary Function Change in Nasopharyngeal Carcinoma Treated by Parotid-sparing Radiotherapy
by: Wen-Shan, et al.
Published: (2007)

The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study
by: Sai-Lan Liu, et al.
Published: (2019-03-01)

Prognostic value of pretreatment and recovery duration of cranial nerve palsy in nasopharyngeal carcinoma
by: Mo Hao-Yuan, et al.
Published: (2012-09-01)

Radiation-induced osteosarcoma of the maxilla and mandible after radiotherapy for nasopharyngeal carcinoma
by: Lie-Qiang Liao, et al.
Published: (2016-10-01)

Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma
by: Yangkun Luo, et al.
Published: (2016-01-01)

Clinical study on ocular complications subsequent to radiotherapy of nasopharyngeal carcinoma
by: Ru Liu, et al.
Published: (2015-09-01)

Prognostic significance of glycosylated hemoglobin in nondiabetic patients in acute coronary syndrome
by: Sushil Singh, et al.
Published: (2016-01-01)

Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?
by: Harun Badakhshi, et al.
Published: (2018-01-01)

A new stage: classification for nasopharyngeal carcinoma based on significant prognosticators.
Published: (1996)

Longitudinal brain structural alterations in patients with nasopharyngeal carcinoma early after radiotherapy
by: Zheng Guo, et al.
Published: (2018-01-01)

Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinoma
by: Jiawei Lv, et al.
Published: (2019-09-01)

Management of Chemotherapy for Stage II Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era: A Review
by: Wu P, et al.
Published: (2020-02-01)

The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
by: Zi-Lu Huang, et al.
Published: (2019-05-01)

Etiology and management of nasopharyngeal hemorrhage after radiotherapy for nasopharyngeal carcinoma
by: Zhan J, et al.
Published: (2019-03-01)